Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Genus PLC, trading under the ticker GNS on the London Stock Exchange, specializes in animal genetics and biotechnology. The company, founded in 1994 and headquartered in Basingstoke, United Kingdom, operates across multiple countries offering genetically superior pig and cattle breeding stock along with state-of-the-art in vitro fertilization products. Genus PLC aims to empower customers in the livestock sector to enhance the efficiency and profitability of their operations by providing innovative genetic solutions and services.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
GenusJohnson & Johnson
Last price
£22.38$263.63
Currency
GBP
USD
£1.5B$621B
5.3039.15
£4.25$6.58
0.910.21
£0.33$5.28
1.46%2.08%
Sector
HealthHealth
Employees
2,921138,200
Ticker
£GNS$JNJ
Primary listing
LSENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in £GNS or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.